Liu W, Cui Y, Zheng X, Yu K, Sun G
Front Oncol. 2023; 13:1098581.
PMID: 37035154
PMC: 10080030.
DOI: 10.3389/fonc.2023.1098581.
Wang C, Shi X
Chin Med J (Engl). 2019; 132(22):2729-2736.
PMID: 31725451
PMC: 6940092.
DOI: 10.1097/CM9.0000000000000524.
Wakefield C, Doolan E, Fardell J, Signorelli C, Quinn V, Tucker K
BMJ Open. 2018; 8(8):e024064.
PMID: 30093523
PMC: 6089310.
DOI: 10.1136/bmjopen-2018-024064.
Farzam P, Johansson J, Mireles M, Jimenez-Valerio G, Martinez-Lozano M, Choe R
Biomed Opt Express. 2017; 8(5):2563-2582.
PMID: 28663891
PMC: 5480498.
DOI: 10.1364/BOE.8.002563.
Brait M, Izumchenko E, Kagohara L, Long S, Wysocki P, Faherty B
Br J Cancer. 2017; 116(4):515-523.
PMID: 28118322
PMC: 5318980.
DOI: 10.1038/bjc.2016.450.
Pathway activation strength is a novel independent prognostic biomarker for cetuximab sensitivity in colorectal cancer patients.
Zhu Q, Izumchenko E, Aliper A, Makarev E, Paz K, Buzdin A
Hum Genome Var. 2016; 2:15009.
PMID: 27081524
PMC: 4785572.
DOI: 10.1038/hgv.2015.9.
Prioritizing therapeutic targets using patient-derived xenograft models.
Lodhia K, Hadley A, Haluska P, Scott C
Biochim Biophys Acta. 2015; 1855(2):223-34.
PMID: 25783201
PMC: 4433556.
DOI: 10.1016/j.bbcan.2015.03.002.
Patient-derived xenograft models: an emerging platform for translational cancer research.
Hidalgo M, Amant F, Biankin A, Budinska E, Byrne A, Caldas C
Cancer Discov. 2014; 4(9):998-1013.
PMID: 25185190
PMC: 4167608.
DOI: 10.1158/2159-8290.CD-14-0001.
Development of a realistic in vivo bone metastasis model of human renal cell carcinoma.
Valta M, Zhao H, Ingels A, Thong A, Nolley R, Saar M
Clin Exp Metastasis. 2014; 31(5):573-84.
PMID: 24715498
PMC: 4351963.
DOI: 10.1007/s10585-014-9651-8.
New cast for a new era: preclinical cancer drug development revisited.
Herter-Sprie G, Kung A, Wong K
J Clin Invest. 2013; 123(9):3639-45.
PMID: 23999436
PMC: 3754257.
DOI: 10.1172/JCI68340.
Tissue slice grafts of human renal cell carcinoma: an authentic preclinical model with high engraftment rate and metastatic potential.
Thong A, Zhao H, Ingels A, Valta M, Nolley R, Santos J
Urol Oncol. 2013; 32(1):43.e23-30.
PMID: 23911681
PMC: 4350678.
DOI: 10.1016/j.urolonc.2013.05.008.
Genomic characterization of explant tumorgraft models derived from fresh patient tumor tissue.
Monsma D, Monks N, Cherba D, Dylewski D, Eugster E, Jahn H
J Transl Med. 2012; 10:125.
PMID: 22709571
PMC: 3439334.
DOI: 10.1186/1479-5876-10-125.
Multi-color palette of fluorescent proteins for imaging the tumor microenvironment of orthotopic tumorgraft mouse models of clinical pancreatic cancer specimens.
Suetsugu A, Katz M, Fleming J, Truty M, Thomas R, Moriwaki H
J Cell Biochem. 2012; 113(7):2290-5.
PMID: 22573550
PMC: 3566777.
DOI: 10.1002/jcb.24099.
Tissue slice grafts: an in vivo model of human prostate androgen signaling.
Zhao H, Nolley R, Chen Z, Peehl D
Am J Pathol. 2010; 177(1):229-39.
PMID: 20472887
PMC: 2893666.
DOI: 10.2353/ajpath.2010.090821.
